Foresite Capital Management IV as of Sept. 30, 2020
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 15 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Relay Therapeutics (RLAY) | 20.5 | $91M | 2.1M | 42.59 | |
| Nurix Therapeutics (NRIX) | 18.5 | $82M | 2.3M | 34.91 | |
| Keros Therapeutics (KROS) | 12.3 | $55M | 1.4M | 38.57 | |
| Kura Oncology (KURA) | 9.0 | $40M | 1.3M | 30.64 | |
| Alx Oncology Hldgs (ALXO) | 8.3 | $37M | 974k | 37.74 | |
| Cytokinetics (CYTK) | 8.2 | $36M | 1.7M | 21.65 | |
| Generation Bio (GBIO) | 6.0 | $27M | 858k | 30.91 | |
| Vaxcyte (PCVX) | 5.2 | $23M | 466k | 49.38 | |
| Myokardia | 3.9 | $17M | 127k | 136.33 | |
| Cymabay Therapeutics | 2.9 | $13M | 1.8M | 7.24 | |
| Arbutus Biopharma (ABUS) | 2.4 | $10M | 3.3M | 3.13 | |
| Voyager Therapeutics (VYGR) | 1.2 | $5.5M | 517k | 10.67 | |
| Therapeutics Acquisition Corp Com Cl A | 1.1 | $5.0M | 350k | 14.38 | |
| Panacea Acquisition Corp Unit | 0.4 | $1.8M | 150k | 12.00 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $372k | 145k | 2.57 |
